Samar Harris, MD
Basic profileNorth Texas Regional Center for Innovation and Commercialization
Samar Harris is a Gastroenterology physician affiliated with North Texas Regional Center for Innovation and Commercialization. OpenAlex indexes 65 publications with 767 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
78.5%Proton pump inhibitor42.1%Omeprazole68%Pantoprazole Sodium32%Part D≥58 patientsSerotonin-4 Receptor Agonist7.1%Motegrity100%Part D<11 patients+ 7 more classes in this area
Nervous system
18.2%Cholinesterase Inhibitor4.4%Pyridostigmine Bromide100%Part D<11 patientsOther antidepressants3.8%Mirtazapine100%Part D<11 patients+ 4 more classes in this area
Respiratory
3.3%Phenothiazine3.3%Promethazine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ALL-1405: Blinatumomab-Induced Acute Pancreatitis: A Case Report
Clinical Lymphoma Myeloma & Leukemia
2025 - ALL-1436: Colonic Perforation Following Induction Chemotherapy With Dasatinib and Blinatumomab for Philadelphia-Positive Acute Lymphoblastic Leukemia
Clinical Lymphoma Myeloma & Leukemia
2025 - HL-085: Paraneoplastic Neurologic Disorder in Hodgkin’s Lymphoma
Clinical Lymphoma Myeloma & Leukemia
2025 - Neurological autoimmune disorders with prominent gastrointestinal manifestations: A review of presentation, evaluation, and treatment
Neurogastroenterology & Motility
2019
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”